APP and Alzheimer disease: This lack of effect of subchronic treatment with GSIs on spatial memory was attributed to the accumulation of APP β-CTF in hippocampal synapses and was consistent with findings in the clinic of worsening of cognition and the ability to perform activities of daily living in AD patients [18].